Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain

Whitehouse, M. W. and Rainsford, K. (2006) Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain. Inflammopharmacology, 14 3-4: 99-102. doi:10.1007/s10787-006-1523-7


Author Whitehouse, M. W.
Rainsford, K.
Title Lipoxygenase inhibition: The neglected frontier for regulating chronic inflammation and pain
Journal name Inflammopharmacology   Check publisher's open access policy
ISSN 0925-4692
Publication date 2006-08-01
Sub-type Article (original research)
DOI 10.1007/s10787-006-1523-7
Volume 14
Issue 3-4
Start page 99
End page 102
Total pages 4
Place of publication Basel, Switzerland
Publisher Birkhauser
Collection year 2006
Language eng
Subject CX
320503 Clinical Pharmacology and Therapeutics
730305 Diagnostic methods
1115 Pharmacology and Pharmaceutical Sciences
Keyword Emu oil(s)
Lyprinol®
5-lipoxygenase
Corticosteroid
‘Steroid-sparing’
Synergy
Q-Index Code CX

Document type: Journal Article
Sub-type: Article (original research)
Collections: Excellence in Research Australia (ERA) - Collection
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: Scopus Citation Count Cited 3 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 15 Aug 2007, 19:55:13 EST